Delivery Order SPE2DB20D3505-SPE2DB22FT7T6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $16,739.80 delivery order is for GLATOPA 40 MG/ML SYRINGEML, which is a pharmaceutical product. The contract has an ultimate completion date of March 1, 2024 and is a firm fixed-price delivery order. The contract was awarded on February 29, 2024 and does not have a set-aside designation, indicating it was a full and open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $9,502.90 firm fixed price contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a medical supply product. The contract has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, is for the supply of GLATOPA 40 MG/ML SYRINGE/ML. The $5,066.52 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 24, 2022. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award is a delivery order valued at $13,340.83 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was issued by the Defense Logistics Agency (DLA), a defense agency, for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and runs through February 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,189.76 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $5,860.96 firm fixed-price delivery order is for the provision of GLATOPA 40 MG/ML syringes, with a performance period extending through July 2, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
- This federal contract award, valued at $32,419.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance ending on March 4, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of GLATOPA 40 MG/ML SYRINGE, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,698.52, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4563034111 - GLATOPA 40 MG/ML SYRINGEML. The contract has a ceiling value of $36,415.17 and an ultimate completion date of December 8, 2023. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Glatopa 40 mg/mL syringes. The $2,533.26 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT7T6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,377.68 Firm Fixed Price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a period of performance through May 10, 2022 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999.00 and $750,000.00 respectively. These IDCs enable Amerisourcebergen to efficiently provide a broad range of pharmaceutical products and medical supplies to support critical healthcare needs across various federal agencies and military/veterans' programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 5/9/22 |